Search

All phases Early Phase 1 Phase 1 Phase 2 Phase 3 Phase 4 Phase 1/2 Phase 2/3

All statuses Open (recruiting or opening soon) Active, not recruiting Completed

25 miles 50 miles 100 miles 200 miles

Newest Nearest Most relevant

Apply Reset

Phenomenological and Psychopathological Factors Associated to Hallucinations in Parkinson's Disease

Trial N/A Terminated Jan. 16, 2019

The Effects of a High Intensity Exercise Training Program in Patients With Parkinson's Disease

Trial N/A Completed Jan. 16, 2019

Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off

Trial Phase 2 Completed Jan. 16, 2019

The Fine Motor Dexterity Under Dual Task in Parkinson's Disease

Trial N/A Unknown Jan. 14, 2019

Effects of Different Percentages Body Weight Supported Treadmill Training on Gait, Balance, Quality of Life and Fatigue in Parkinson's Disease

Trial N/A Completed Jan. 9, 2019

Multi-electrodes Set for Deep Brain Stimulation in Parkinson Disease

Trial Early Phase 1 Terminated Jan. 8, 2019

Personality, as a Predictive Factor of Therapeutic Response on Quality of Life After Continuous Perfusion of Dopaminergic Drugs, in Parkinson's Disease

Trial N/A Unknown Jan. 3, 2019

the Prevalence of "Wearing-off" in Patients With Parkinson's Disease in Shanghai

Trial N/A Completed Jan. 2, 2019

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ITI-214 in Parkinson's Disease

Trial Phase 1 Completed Dec. 19, 2018

3D or 2D Upper Extremity Exergaming for Persons With Parkinson's Disease

Trial N/A Completed Dec. 18, 2018

Moving Through Glass: An Augmented Reality Device Application for Persons With Parkinson's Disease

Trial N/A Completed Dec. 3, 2018

Effectiveness of MIRT on Hand and Finger Dexterity in PD Patients

Trial N/A Completed Dec. 3, 2018

Physical Training Induced Plasticity of Motor Control Mechanisms in Parkinson's Disease Patients

Trial N/A Completed Dec. 2, 2018

Methylphenidate and Parkinson's Disease

Trial Phase 2 Completed Nov. 28, 2018

Low Dose Apomorphine and Parkinsonism

Trial Phase 2 Withdrawn Nov. 28, 2018

Atomoxetine for Freezing of Gait in Parkinson's Disease

Trial Phase 3 Completed Nov. 27, 2018

Multimodal Exercise Program on Parkinson's Disease Patients With Depression

Trial N/A Completed Nov. 25, 2018

A Study in Patients With Advanced Parkinson's Disease to Assess the Relative Bioavailability of Levodopa Administered as ND0612 Subcutaneous Infusion Versus Levodopa Administered as Carbidopa-Levodopa Enteral Suspension

Trial Phase 3 Withdrawn Nov. 22, 2018

Treatment of Parkinson Disease and Multiple System Atrophy Using Intranasal Insulin.

Trial Phase 2 Completed Nov. 22, 2018

Gait Disorders in Parkinson's Disease

Trial Early Phase 1 Withdrawn Nov. 19, 2018